Neonatal and Pregnancy Outcome in Primary Antiphospholipid Syndrome: A 10-year Experience in One Medical Center
Article Outline
Background
Antiphospholipid syndrome (APS) in pregnancy is characterized by the presence of maternal autoantibodies in association with recurrent fetal loss and severe obstetric complications such as prematurity, intrauterine growth retardation, or placental insufficiency. This study aimed to assess the perinatal outcomes in neonates born to mothers with APS.
Methods
The medical records of pregnant women with APS and their offspring were retrospectively collected between January 1997 and July 2007. Maternal and perinatal histories including demographic data, medications, obstetric histories, and neonatal clinical manifestations and laboratory data were analyzed.
Results
Eleven women with a diagnosis of primary APS were included. Eight of these patients had experienced frequent spontaneous abortions (72.7%), and four had unexplained fetal deaths (36.3%). None of them had vascular thrombosis. Specific autoimmune antibodies were detected, including anticardiolipin antibody (n = 6), anti-β2 glycoprotein I (n = 3), and antiphospholipid antibody (n = 7). Among the pregnancies, five had preterm births (45.4%), two had intrauterine growth retardation (18.1%), and one had intrauterine fetal demise (9.1%). Thrombocytopenia was noted in three babies, all of whose mothers had lower platelet counts. One patient with neonatal thrombocytopenia developed intracranial hemorrhage, seen on brain images.
Conclusions
This limited study suggests that neonates born to mothers with primary APS are at risk of prematurity, being small for gestational age, and having thrombocytopenia. Further large, prospective studies are required to better define the perinatal outcomes.
Key Words: antiphospholipid syndrome , maternal and neonatal outcome , preterm birth , small for gestational age , thrombocytopenia
No full text is available. To read the body of this article, please view the PDF online.
References
- . Antiphospholipid syndrome: obstetric diagnosis, management, and controversies . Obstet Gynecol . 2003;101:1333–1344
- . Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome . J Perinat Med . 1999;27:183–187
- . Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin . Br J Obstet Gynaecol . 1999;106:102–107
- . An unusual cause of neonatal seizures in a newborn infant . Pediatrics . 1997;100:E8
- . Fetal stroke associated with elevated maternal anticardiolipin antibodies . Obstet Gynecol . 1992;80(3 Pt 2):497–499
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) . J Thromb Haemost . 2006;4:295–306
- Nationwide singleton birth weight percentiles by gestational age in Taiwan, 1998–2002 . Acta Paediatr Taiwanica . 2006;47:25–33
- . Antiphospholipid antibodies and fetal death . Obstet Gynecol . 1996;87:489–493
- . Hemocoagulative pathology and immunological recurrent abortion . Clin Exp Obstet Gynecol . 1997;24:39–40
- . Animal models of antiphospholipid syndrome . Rev Rhum Engl Ed . 1998;65:614–618
- . The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome . Am J Reprod Immunol . 1998;39:125–136
- Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I . Arthritis Rheum . 2000;43:140–150
- . Antiphospholipid antibody. Babies, blood clots, biology . JAMA . 1997;277:1549–1551
- Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome . J Clin Invest . 2003;112:1644–1654
- Pregnancy and neonatal outcome in primary antiphospholipid syndrome . Lupus . 2002;11:649
- . Multiple thromboses in a premature infant associated with maternal phospholipid antibody syndrome . J Perinatol . 1994;14:66–70
- . Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment . Ann Med Interne (Paris) . 1996;147(Suppl 1):24–27
- . Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome . Br J Haematol . 1997;98:873–879
- . Specificities of platelet autoantibodies in patients with lupus anticoagulants in primary antiphospholipid syndrome . Ann Hematol . 1997;74:239–242
- Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients . Clin Exper Rheumatol . 1997;15:143–149
PII: S1875-9572(09)60052-8
doi:10.1016/S1875-9572(09)60052-8
© 2009 Taiwan Pediatric Association. Published by Elsevier Inc. All rights reserved.
